MRI screening for brain metastases in high-risk cancers
Treatments studied
Part of Cancer, Lungs & breathing, Skin clinical trials.
This trial uses regular MRI scans to screen for brain metastases in people with certain advanced cancers (HER2-positive or triple-negative breast cancer, non-small cell lung cancer, or melanoma). The goal is to detect brain spread early, which may help guide treatment and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with HER2-positive or triple-negative breast cancer, non-small cell lung cancer, or melanoma that has spread or is at high risk of spreading to the brain.
- You must be at least 18 years old.
- You must be able to have MRI scans (no metal implants, no severe claustrophobia).
- You must have adequate kidney function (a blood test will check this).
- You must be generally well enough to undergo scans (a performance score of 60 or higher on the Karnofsky scale).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether routine brain scans can help manage breast cancer that has spread to other parts of the body. It aims to find brain metastases early in people with certain types of high-risk breast cancer, even before symptoms appear.
This trial uses an MRI scan to look for early signs of breast cancer spreading to the brain in people with certain aggressive breast cancer types (triple-negative or HER2-positive) that are stage IIb or III. The goal is to find and treat brain metastases earlier, before they cause symptoms.
This trial looks at whether doing an MRI scan of the brain for people with stage IV lung cancer helps in their care. The goal is to find brain issues early (if present) so treatment decisions can be made sooner.
This trial checks whether taking screening brain MRI scans in people with stage IV breast cancer helps find brain involvement earlier. It may help guide treatment decisions for those who would otherwise only get brain imaging after symptoms start.
This trial checks the brain using MRI in people with breast cancer that has spread outside the breast or can’t be fully removed. The goal is to screen for brain involvement and see how MRI findings fit with treatment timing, when it’s safe to do so.
This study tests a new MRI sequence to see if it can better detect brain metastases. You may be eligible if you are scheduled for a brain MRI with contrast and have known or suspected brain metastases.
Hear when a new Lung Cancer Stage IV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.